As many of you surely know, Clinical List America is one of the premier firms for clinical trial recruitment. Understanding the importance of clinical trials and their advancement of medicine and betterment of people’s health, it is our goal to provide the most innovative, effective clinical trial recruitment strategies to our clients. In addition, it is also our priority to maintain our knowledge of news and trends in the industry.

With that said, we recently learned about a clinical research related event that we wanted to share with you. According to an article released by CenterWatch, on April 25 – 26, 2013 the FDA will hold the first public workshop to discuss, “how to facilitate and expedite the development of safe, effective drug therapies to treat myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).” The workshop, which is scheduled to stream live online, will be open to clinical research professionals, including pharmaceutical companies, researchers and clinicians, as well as patients.

With currently no FDA-approved medications for this indication, we felt the need to share the news of this event. Hopefully, by helping publicize this workshop, we can assist in moving one step closer to helping the more than one million people that currently suffer from ME/CFS. To read the CenterWatch article and learn more about/register for this workshop, please click here.

Or, if you have any questions for our team, please contact us at 1-888-299-1202 or info@clinicallistamerica.com.